2024 Q3 Form 10-K Financial Statement

#000149315224029074 Filed on July 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2024
Revenue $1.301M $1.572M $5.525M
YoY Change 2.28% 60.41% 102.23%
Cost Of Revenue $854.0K $710.0K $2.699M
YoY Change 40.23% -36.27% 8.13%
Gross Profit $447.0K $862.0K $2.826M
YoY Change -32.58% -743.28% 1097.46%
Gross Profit Margin 34.36% 54.83% 51.15%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $500.0K $7.700M
YoY Change -73.68% -23.0%
% of Gross Profit 111.86% 272.47%
Depreciation & Amortization $204.0K $168.0K $420.0K
YoY Change 187.32% 158.46% 23.17%
% of Gross Profit 45.64% 19.49% 14.86%
Operating Expenses $4.920M $7.626M $32.16M
YoY Change -39.28% -21.8% 9.18%
Operating Profit -$4.473M -$6.764M -$29.33M
YoY Change -39.37% -31.58% 0.39%
Interest Expense $3.000K $40.00K $802.0K
YoY Change -99.12% -86.53% -11.18%
% of Operating Profit
Other Income/Expense, Net $17.00K $2.000K $2.000K
YoY Change -95.92% -99.88%
Pretax Income -$4.453M -$6.722M -$28.74M
YoY Change -36.74% -29.54% 8.02%
Income Tax $0.00 -$1.254M
% Of Pretax Income
Net Earnings -$4.500M -$6.722M -$27.50M
YoY Change -35.71% -29.54% 4.46%
Net Earnings / Revenue -345.89% -427.61% -497.74%
Basic Earnings Per Share -$0.05 -$0.47
Diluted Earnings Per Share -$0.05 -$0.11 -$0.47
COMMON SHARES
Basic Shares Outstanding 92.71M shares 59.03M shares
Diluted Shares Outstanding 81.95M shares 59.03M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.182M $3.151M $3.151M
YoY Change -88.06% -90.91% -90.91%
Cash & Equivalents $3.182M $3.151M $3.151M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $785.0K $1.747M $1.747M
YoY Change 26.82% 64.97% 64.97%
Inventory $5.681M $4.831M $4.831M
Prepaid Expenses
Receivables $963.0K $796.0K $814.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $11.09M $10.54M $10.54M
YoY Change -63.15% -72.01% -72.01%
LONG-TERM ASSETS
Property, Plant & Equipment $3.613M $3.443M $5.848M
YoY Change 169.23% 13.59% 92.94%
Goodwill $8.537M $8.537M
YoY Change 0.0% 0.0%
Intangibles $3.589M $3.622M
YoY Change -8.86% -8.95%
Long-Term Investments
YoY Change
Other Assets $154.0K $154.0K $154.0K
YoY Change -1.28% -0.65% -0.65%
Total Long-Term Assets $18.09M $18.16M $18.16M
YoY Change 16.05% 15.67% 15.67%
TOTAL ASSETS
Total Short-Term Assets $11.09M $10.54M $10.54M
Total Long-Term Assets $18.09M $18.16M $18.16M
Total Assets $29.18M $28.70M $28.70M
YoY Change -36.12% -46.22% -46.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.741M $3.366M $3.366M
YoY Change 34.23% 253.57% 253.57%
Accrued Expenses $1.579M $1.787M $2.561M
YoY Change 1.48% -37.84% -10.92%
Deferred Revenue $445.0K $302.0K
YoY Change -63.13% -78.08%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.141M $7.359M $7.359M
YoY Change -10.51% -6.93% -6.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.525M $1.798M $1.798M
YoY Change 30.57% 37.15% 37.15%
Total Long-Term Liabilities $1.525M $1.798M $1.798M
YoY Change 30.57% 37.15% 37.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.141M $7.359M $7.359M
Total Long-Term Liabilities $1.525M $1.798M $1.798M
Total Liabilities $6.869M $9.360M $9.360M
YoY Change -3.47% -0.65% -0.65%
SHAREHOLDERS EQUITY
Retained Earnings -$312.0M -$307.6M
YoY Change 8.68% 9.81%
Common Stock $96.00K $61.00K
YoY Change 62.71% 8.93%
Preferred Stock
YoY Change
Treasury Stock (at cost) $369.0K $369.0K
YoY Change 3.36% 3.94%
Treasury Stock Shares
Shareholders Equity $22.31M $19.34M $19.34M
YoY Change
Total Liabilities & Shareholders Equity $29.18M $28.70M $28.70M
YoY Change -36.12% -46.22% -46.22%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2024
OPERATING ACTIVITIES
Net Income -$4.500M -$6.722M -$27.50M
YoY Change -35.71% -29.54% 4.46%
Depreciation, Depletion And Amortization $204.0K $168.0K $420.0K
YoY Change 187.32% 158.46% 23.17%
Cash From Operating Activities -$6.100M -$5.052M -$29.80M
YoY Change -23.75% -10.07% 37.28%
INVESTING ACTIVITIES
Capital Expenditures $374.0K $1.361M $2.585M
YoY Change 181.2% 89.82% 153.68%
Acquisitions
YoY Change
Other Investing Activities $0.00 $4.391M $28.08M
YoY Change -100.0% 91.0% 30.72%
Cash From Investing Activities -$374.0K $3.030M $25.50M
YoY Change -107.52% 91.53% 24.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $14.00K
YoY Change -200.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $6.529M 453.0K $469.0K
YoY Change -326550.0% -3450.0%
NET CHANGE
Cash From Operating Activities -$6.100M -5.052M -$29.80M
Cash From Investing Activities -$374.0K 3.030M $25.50M
Cash From Financing Activities $6.529M 453.0K $469.0K
Net Change In Cash $31.00K -1.569M -$3.798M
YoY Change -101.02% -61.12% 201.67%
FREE CASH FLOW
Cash From Operating Activities -$6.100M -$5.052M -$29.80M
Capital Expenditures $374.0K $1.361M $2.585M
Free Cash Flow -$6.474M -$6.413M -$32.39M
YoY Change -20.4% 1.23% 42.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001378140
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
usd
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024 OPTT Other Income Employee Retention Credit
OtherIncomeEmployeeRetentionCredit
usd
CY2024 us-gaap Insurance Recoveries
InsuranceRecoveries
usd
CY2023 us-gaap Other Income
OtherIncome
usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2024 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2024 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
usd
CY2024 us-gaap Payments To Acquire Lease Receivables
PaymentsToAcquireLeaseReceivables
usd
CY2023 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2023 OPTT Proceeds From Issuance Initial Public Offering Agp
ProceedsFromIssuanceInitialPublicOfferingAGP
usd
CY2024 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2023 us-gaap Stock Issued1
StockIssued1
usd
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
usd
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
usd
CY2024Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
usd
CY2024 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
CY2024Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
usd
CY2024Q2 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
usd
CY2024Q2 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
usd
CY2024Q2 us-gaap Construction Payable Current
ConstructionPayableCurrent
usd
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
pure
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-04-30
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Public Float
EntityPublicFloat
17600000 usd
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
92708981 shares
CY2024 dei Auditor Firm
AuditorFirmId
274
CY2024 dei Auditor Name
AuditorName
EISNERAMPER LLP
CY2024 dei Auditor Location
AuditorLocation
Iselin, New Jersey
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3151000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6883000 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
27790000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
65000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
796000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
745000 usd
CY2024Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
18000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
152000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
4831000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1044000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1747000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
994000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
10543000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
37673000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3443000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1280000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3622000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3978000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2405000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1751000 usd
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
154000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
155000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
8537000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
8537000 usd
CY2024Q2 us-gaap Assets
Assets
28704000 usd
CY2023Q2 us-gaap Assets
Assets
53374000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3366000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
952000 usd
CY2024Q2 OPTT Earn Out Payable Current
EarnOutPayableCurrent
1130000 usd
CY2023Q2 OPTT Earn Out Payable Current
EarnOutPayableCurrent
1500000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1787000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2346000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
302000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1378000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
774000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
529000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1202000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7359000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7907000 usd
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
203000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
203000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1798000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1311000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
9360000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
9421000 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61352731 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56304642 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61264714 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56263728 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
61000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
56000 usd
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
88017 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
40914 shares
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
369000 usd
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
355000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
327276000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
324393000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-307579000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-280096000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-45000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-45000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
19344000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43953000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28704000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53374000 usd
CY2024 us-gaap Revenues
Revenues
5525000 usd
CY2023 us-gaap Revenues
Revenues
2732000 usd
CY2024 us-gaap Cost Of Revenue
CostOfRevenue
2699000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
2496000 usd
CY2024 us-gaap Gross Profit
GrossProfit
2826000 usd
CY2023 us-gaap Gross Profit
GrossProfit
236000 usd
CY2024 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-72000 usd
CY2024 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
32229000 usd
CY2023 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
28340000 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
32157000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
29452000 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-29331000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-29216000 usd
CY2024 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
800000 usd
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
902000 usd
CY2023 OPTT Other Income Employee Retention Credit
OtherIncomeEmployeeRetentionCredit
1251000 usd
CY2023 us-gaap Insurance Recoveries
InsuranceRecoveries
458000 usd
CY2024 us-gaap Other Income
OtherIncome
2000 usd
CY2024 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-210000 usd
CY2024 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2000 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28737000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26604000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1254000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-278000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-26326000 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59031736 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59031736 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55998543 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55998543 shares
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-27483000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-26326000 usd
CY2024 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-27483000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-26326000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
68831000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-26326000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1461000 usd
CY2023 OPTT Stock Issued During Period Value Shares Withheld For Tax Withholdings
StockIssuedDuringPeriodValueSharesWithheldForTaxWithholdings
14000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43953000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43953000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-27483000 usd
CY2024 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1155000 usd
CY2024 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1250000 usd
CY2024 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
29000 usd
CY2024 OPTT Stock Issued During Period Value Net Of Issuance Costs
StockIssuedDuringPeriodValueNetOfIssuanceCosts
454000 usd
CY2024 OPTT Stock Issued During Period Value Shares Withheld For Tax Withholdings
StockIssuedDuringPeriodValueSharesWithheldForTaxWithholdings
14000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
19344000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
19344000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-27483000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-26326000 usd
CY2024 OPTT Foreign Currency Transaction Gain Loss Net Of Tax
ForeignCurrencyTransactionGainLossNetOfTax
2000 usd
CY2023 OPTT Foreign Currency Transaction Gain Loss Net Of Tax
ForeignCurrencyTransactionGainLossNetOfTax
1000 usd
CY2024 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
420000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
183000 usd
CY2024 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
148000 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
158000 usd
CY2024 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
593000 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
296000 usd
CY2024 OPTT Amortization Of Premium On Investments
AmortizationOfPremiumOnInvestments
290000 usd
CY2023 OPTT Amortization Of Premium On Investments
AmortizationOfPremiumOnInvestments
-113000 usd
CY2024 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-72000 usd
CY2023 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1112000 usd
CY2024 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-210000 usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
1155000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1461000 usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
51000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
262000 usd
CY2024 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-134000 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-234000 usd
CY2024 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3787000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
602000 usd
CY2024 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
753000 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
527000 usd
CY2024 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2414000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
47000 usd
CY2024 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-309000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1469000 usd
CY2024 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-500000 usd
CY2024 OPTT Increase Decrease In Right Of Use Liability
IncreaseDecreaseInRightOfUseLiability
-514000 usd
CY2023 OPTT Increase Decrease In Right Of Use Liability
IncreaseDecreaseInRightOfUseLiability
-311000 usd
CY2024 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1076000 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1249000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21707000 usd
CY2024 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
35975000 usd
CY2023 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
64923000 usd
CY2024 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
7894000 usd
CY2023 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
43442000 usd
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2585000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
648000 usd
CY2023 us-gaap Payments To Acquire Lease Receivables
PaymentsToAcquireLeaseReceivables
371000 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
25496000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
20462000 usd
CY2024 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
29000 usd
CY2024 OPTT Proceeds From Issuance Initial Public Offering Agp
ProceedsFromIssuanceInitialPublicOfferingAGP
454000 usd
CY2024 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
14000 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
14000 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
469000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14000 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3798000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1259000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7103000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8362000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3305000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7103000 usd
CY2024 us-gaap Stock Issued1
StockIssued1
1250000 usd
CY2024 OPTT Operating Right Of Use Asset Obtained In Exchange For Operating Lease Liability
OperatingRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1247000 usd
CY2023 OPTT Operating Right Of Use Asset Obtained In Exchange For Operating Lease Liability
OperatingRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1296000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-27500000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-26300000 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29800000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21700000 usd
CY2024 OPTT Incurred Expenses
IncurredExpenses
3900000 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zMRAI47wswTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(b) <span id="xdx_863_zuHfVHrMuqfj">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements requires management of the Company to make several estimates and assumptions relating to the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the period. Significant items subject to such estimates and assumptions include, among other items, stock-based compensation based on actual and projected revenues, over time revenue recognition, valuation consideration related to business combinations, including contingent consideration based on actual and projected revenues, including discount rates and present values, and other assumptions and estimates used to evaluate the recoverability of long-lived assets, goodwill and other intangible assets. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
CY2024Q2 OPTT Revenue Remaining Performance Obligations
RevenueRemainingPerformanceObligations
4900000 usd
CY2024Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
3300000 usd
CY2023Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
7100000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3151000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6883000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
65000 usd
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
154000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
155000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3305000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7103000 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
27800000 usd
CY2024 OPTT Accretion Of Discount Amortization Of Premium On Investment
AccretionOfDiscountAmortizationOfPremiumOnInvestment
290000 usd
CY2023 OPTT Accretion Of Discount Amortization Of Premium On Investment
AccretionOfDiscountAmortizationOfPremiumOnInvestment
122000 usd
CY2023Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
27790000 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
158000 usd
CY2023Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
27948000 usd
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_z64fBt7EcpIb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(j) <span id="xdx_866_z1v7owuqll6h">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to credit risk consist principally of trade accounts receivable, short-term investments and cash equivalents. The Company believes that its credit risk is limited because the Company’s current contracts are with entities with a reliable payment history. The Company invests its excess cash in a money market fund and short-term held-to maturity investments and does not believe that it is exposed to any significant risks related to its cash accounts, money market fund, or held-to maturity investments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the year ended April 30, 2024 and 2023, the Company had four and two customers whose revenue accounted for at least 10% of the Company’s consolidated revenue, respectively. These customers accounted for approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230501__20240430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zikLiOes8bKf" title="Concentration risk percentage">52</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220501__20230430__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zR9toZbYaEde" title="Concentration risk percentage">32</span>% of the Company’s total revenue for the respective periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5859072 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7777026 shares
CY2024 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1200000 usd
CY2023 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1500000 usd
CY2024 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7700000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10000000.0 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
796000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
745000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
482000 usd
CY2024Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
18000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
152000 usd
CY2022Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
386000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
302000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1378000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
129000 usd
CY2024 OPTT Transferred To Receivables From Contract Assets Recognized
TransferredToReceivablesFromContractAssetsRecognized
1879000 usd
CY2023 OPTT Transferred To Receivables From Contract Assets Recognized
TransferredToReceivablesFromContractAssetsRecognized
1768000 usd
CY2024 OPTT Revenue Recognized And Not Billed
RevenueRecognizedAndNotBilled
1745000 usd
CY2023 OPTT Revenue Recognized And Not Billed
RevenueRecognizedAndNotBilled
1534000 usd
CY2024 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-134000 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-234000 usd
CY2024 OPTT Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
2424000 usd
CY2023 OPTT Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
574000 usd
CY2024 OPTT Payments Collected For Which Revenue Has Not Been Recognized
PaymentsCollectedForWhichRevenueHasNotBeenRecognized
1348000 usd
CY2023 OPTT Payments Collected For Which Revenue Has Not Been Recognized
PaymentsCollectedForWhichRevenueHasNotBeenRecognized
1823000 usd
CY2024 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1076000 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1249000 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
4298000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1044000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
397000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
136000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
4831000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1044000 usd
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
202000 usd
CY2023Q2 us-gaap Prepaid Insurance
PrepaidInsurance
358000 usd
CY2024Q2 OPTT Prepaid Software And Licenses
PrepaidSoftwareAndLicenses
224000 usd
CY2023Q2 OPTT Prepaid Software And Licenses
PrepaidSoftwareAndLicenses
190000 usd
CY2024Q2 OPTT Prepaid Sales And Marketing
PrepaidSalesAndMarketing
124000 usd
CY2023Q2 OPTT Prepaid Sales And Marketing
PrepaidSalesAndMarketing
122000 usd
CY2024Q2 OPTT Prepaid Project Costs
PrepaidProjectCosts
578000 usd
CY2023Q2 OPTT Prepaid Project Costs
PrepaidProjectCosts
46000 usd
CY2024Q2 OPTT Prepaid Inventory Materials
PrepaidInventoryMaterials
414000 usd
CY2023Q2 OPTT Prepaid Inventory Materials
PrepaidInventoryMaterials
58000 usd
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
205000 usd
CY2023Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
220000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1747000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
994000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5416000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2851000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1973000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1571000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3443000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1280000 usd
CY2024 us-gaap Depreciation
Depreciation
420000 usd
CY2023 us-gaap Depreciation
Depreciation
183000 usd
CY2024Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
2729000 usd
CY2023Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
2729000 usd
CY2024Q2 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
2769000 usd
CY2023Q2 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
2769000 usd
CY2023Q2 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
130000 usd
CY2023Q2 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
150000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5498000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5778000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1876000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1800000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3622000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3978000 usd
CY2024 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
148000 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
158000 usd
CY2024 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q2 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P2Y
CY2024 us-gaap Operating Lease Expense
OperatingLeaseExpense
700000 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
400000 usd
CY2024 us-gaap Operating Lease Cost
OperatingLeaseCost
640000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
382000 usd
CY2024 us-gaap Short Term Lease Cost
ShortTermLeaseCost
68000 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
44000 usd
CY2024 us-gaap Lease Cost
LeaseCost
708000 usd
CY2023 us-gaap Lease Cost
LeaseCost
426000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2405000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
774000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1798000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2572000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y11M23D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.084 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1410000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1847000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
329000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
333000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
28000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3947000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1375000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2572000 usd
CY2024Q2 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
1271000 usd
CY2023Q2 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
1948000 usd
CY2024Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
369000 usd
CY2023Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
52000 usd
CY2023Q2 us-gaap Construction Payable Current
ConstructionPayableCurrent
181000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
147000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
165000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1787000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2346000 usd
CY2024Q2 OPTT Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Exercised
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised
732500 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1529185 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.75
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M18D
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
794369 shares
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.29
CY2024 OPTT Stock Issued During Period Shares Stock Options Expired
StockIssuedDuringPeriodSharesStockOptionsExpired
273 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
341.08
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
734543 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.12
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M6D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
462150 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.85
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y1M6D
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
200000 usd
CY2024 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y4M24D
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-28737000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-26578000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-26000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28737000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26604000 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.035 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.040 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.011 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.019 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.004 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.011 pure
CY2024 OPTT Effective Income Tax Reconciliation Proceeds Of Sale Of New Jersey Tax Benefits
EffectiveIncomeTaxReconciliationProceedsOfSaleOfNewJerseyTaxBenefits
-0.034 pure
CY2023 OPTT Effective Income Tax Reconciliation Proceeds Of Sale Of New Jersey Tax Benefits
EffectiveIncomeTaxReconciliationProceedsOfSaleOfNewJerseyTaxBenefits
-0.070 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.045 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.013 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.198 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.229 pure
CY2024 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.043 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.010 pure
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
48745000 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
43788000 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
2059000 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
2059000 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1934000 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1578000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
5404000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
5143000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
470000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
662000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
312000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
474000 usd
CY2024Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2578000 usd
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1977000 usd
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
61502000 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
55681000 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
60322000 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
54644000 usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1180000 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1037000 usd
CY2024Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
793000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
792000 usd
CY2024Q2 OPTT Deferred Tax Liabilities Other Liabilities
DeferredTaxLiabilitiesOtherLiabilities
590000 usd
CY2023Q2 OPTT Deferred Tax Liabilities Other Liabilities
DeferredTaxLiabilitiesOtherLiabilities
448000 usd
CY2024Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
203000 usd
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
203000 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
60300000 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
54600000 usd
CY2024 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
5700000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
7000000.0 usd
CY2024Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
231400000 usd
CY2024 OPTT Operating Loss Carryforwards Expiration Description
OperatingLossCarryforwardsExpirationDescription
begin to expire in fiscal 2024
CY2024Q2 OPTT Operating Loss Carryforwards Subject To No Expiration
OperatingLossCarryforwardsSubjectToNoExpiration
97900000 usd
CY2024 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
the deductibility of such federal net operating losses may be limited to 80% of our taxable income in future years.
CY2023Q2 us-gaap Loss Contingency Allegations
LossContingencyAllegations
on April 24, 2024, Paragon made the following “non-dilutive $3MM preferred stock” offer to the Company: “...The preferred would have the option to be convertible to common stock, at $0.05 a share, or 25% of the 30-day average trading price, whichever is higher...”. After the Board correctly rejected the $3MM preferred stock offer, on June 7, 2024, Paragon issued a press release that proclaimed its offer was non-dilutive. In fact, Paragon’s offer was highly dilutive because the offer stipulated that the proposed OPT preferred stock to be issued to Paragon would be convertible to OPT common stock at a 75% discount to the fair market value of the common stock. The Paragon offer thus essentially amounted to a change in control of the Company at 25% of its fair market value.
CY2023Q2 us-gaap Legal Fees
LegalFees
3900000 usd
CY2024 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
1 pure
CY2024 OPTT Employee Contribution Percentage
EmployeeContributionPercentage
0.03 pure
CY2024 OPTT Employee Contribution Percentage Maximum
EmployeeContributionPercentageMaximum
0.06 pure

Files In Submission

Name View Source Status
0001493152-24-029074-index-headers.html Edgar Link pending
0001493152-24-029074-index.html Edgar Link pending
0001493152-24-029074.txt Edgar Link pending
0001493152-24-029074-xbrl.zip Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-3.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
optt-20240430.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
optt-20240430_cal.xml Edgar Link unprocessable
optt-20240430_def.xml Edgar Link unprocessable
optt-20240430_lab.xml Edgar Link unprocessable
optt-20240430_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending